APP and Alzheimer disease: Additionally, in an APP/PS1 transgenic mouse model, NEAT1 is increased and promotes the pathogenesis of AD via upregulating PTEN-induced putative kinase 1 (PINK1)'s ubiquitination and degradation, which provided a potential therapeutic strategy in AD (159) (Table 4).